East Rutherford, NJ – Cambrex Corporation (NYSE: CBM, “Cambrex”) will be exhibiting its small molecule API products and services designed to accelerate the commercialization of finished drug products at Informex USA 2015, February 3-5 in New Orleans, LA. In addition, Cambrex will be presenting at the Informex Exhibitor Showcase on February 3.
Cambrex will be showcasing its API custom development and manufacturing capabilities including analytical development, process validation and drug product formulation with a portfolio of offerings that includes controlled substances, high potency APIs, high energy chemistries, drug delivery and biocatalysis. Cambrex manufactures over 100 generic and branded APIs, as well as advanced pharmaceutical intermediates.
During the Informex Exhibitor Showcase, Joshua Van Kley, Sales Operations Manager, will present Quality and Customer Focus at Cambrex, highlighting Cambrex’s commitment to providing reliable custom API development and manufacturing services to the pharmaceutical industry for more than 30 years.
Cambrex invites you to meet with us at booth 1829 in the Morial Convention Center in New Orleans during Informex USA.